-  - Var. - Volume Denaro- Lettera- Capitalizzazione di mercato Dividend Y. Rapporto P/E
-SGD - -
Fatturato: -
-Quantità in denaro: - -Quantità in lettera: - 54.36 bill.SGD - -

Descrizione business

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life. Not only is the company a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens. Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Albert M. Baehny
Consiglio di amministrazione
Jean-Marc Huët, Philippe Deecke, Caroline Barth, Gordon Bates, Jean-Christophe Hyvert, Maria Soler Nunez, Christian Seufert, Daniel Palmacci
Consiglio di sorveglianza
Angelica Kohlmann, Barbara M. Richmond, Christoph Mäder, Juergen B. Steinemann, Olivier Verscheure, Roger Nitsch, Marion Helmes
 

Dati aziendali

Name: Lonza Group AG
Indirizzo: Münchensteinerstraße 38,Basel
Telefono: +41-61-31681-11
Fax: +41-61-31691-11
E-mail: info@lonza.com
Internet: www.lonzagroup.com/
Industria: Commodities
Settore: Chemicals
Sub settore: -
Fine dell'anno finanziario: 31/12
Flottante libero: 99.70%
Data dell'IPO: 02/11/1999

Rapporti con gli investitori

Name: Lyle Wheeler
IR telefono: +41 79 154 9522
IR Fax: -
IR e-mail: investor.relations@lonza.com

Company calendar

CW 30 | 25/07/2024 Interim Report 2nd Quarter/6 Months
 

Principali azionisti

Altri
 
83.90%
BlackRock, Inc
 
9.85%
UBS Fund Management (Switzerland) AG
 
6.25%